Healthcare provider profile · identity verified

Krista Bruno

Nurse Practitioner · STATEN ISLAND, NY · NPI 1366148298

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Fluticasone Propionate	Fluticasone Propionate	135	86
Atorvastatin Calcium	Atorvastatin Calcium	119	49
Albuterol Sulfate Hfa	Albuterol Sulfate	104	51
Amlodipine Besylate	Amlodipine Besylate	100	42
Gabapentin	Gabapentin	85	43
Azithromycin	Azithromycin	84	79
Prednisone	Prednisone	80	71
Metformin Hcl	Metformin Hcl	76	36
Hydrochlorothiazide	Hydrochlorothiazide	75	34
Zolpidem Tartrate	Zolpidem Tartrate	72	32
Alprazolam	Alprazolam	69	32
Furosemide	Furosemide	68	26
Levothyroxine Sodium	Levothyroxine Sodium	68	32
Rosuvastatin Calcium	Rosuvastatin Calcium	64	26
Simvastatin	Simvastatin	60	25
Buspirone Hcl	Buspirone Hcl	57	22
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	56	54
Losartan Potassium	Losartan Potassium	54	31
Methylprednisolone	Methylprednisolone	53	46
Pantoprazole Sodium	Pantoprazole Sodium	50	23
Doxycycline Hyclate	Doxycycline Hyclate	49	47
Metoprolol Succinate	Metoprolol Succinate	49	21
Mupirocin	Mupirocin	48	33
Famotidine	Famotidine	44	21
Trazodone Hcl	Trazodone Hcl	41	16
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	38	24
Tamsulosin Hcl	Tamsulosin Hcl	38	16
Lisinopril	Lisinopril	37	16
Promethazine Hcl	Promethazine Hcl	37	35
Diclofenac Sodium	Diclofenac Sodium	36	17
Levofloxacin	Levofloxacin	34	31
Eliquis	Apixaban	33	19
Clindamycin Hcl	Clindamycin Hcl	32	31
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	29	16
Ozempic	Semaglutide	29	suppressed
Omeprazole	Omeprazole	28	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	27	25
Silver Sulfadiazine	Silver Sulfadiazine	27	17
Tizanidine Hcl	Tizanidine Hcl	27	suppressed
Donepezil Hcl	Donepezil Hcl	26	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	21
Bupropion Xl	Bupropion Hcl	23	14
Escitalopram Oxalate	Escitalopram Oxalate	23	suppressed
Sertraline Hcl	Sertraline Hcl	23	suppressed
Cefdinir	Cefdinir	21	19
Meloxicam	Meloxicam	21	13
Montelukast Sodium	Montelukast Sodium	21	suppressed
Glimepiride	Glimepiride	20	suppressed
Sucralfate	Sucralfate	20	15
Amoxicillin	Amoxicillin	19	18
Clopidogrel	Clopidogrel Bisulfate	19	suppressed
Tramadol Hcl	Tramadol Hcl	19	suppressed
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	18	14
Triamcinolone Acetonide	Triamcinolone Acetonide	18	suppressed
Celecoxib	Celecoxib	17	suppressed
Potassium Chloride	Potassium Chloride	17	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	17	suppressed
Lovastatin	Lovastatin	16	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Carvedilol	Carvedilol	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Alendronate Sodium	Alendronate Sodium	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Duloxetine Hcl	Duloxetine Hcl	13	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	13	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	11
Pravastatin Sodium	Pravastatin Sodium	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Cephalexin	Cephalexin	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Lorazepam	Lorazepam	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error